Prophylactic Action of Moringa oleifera against Cyclophosphamide-Induced Harmful Effects in Male Mice

Zainab Haytham Razooki1, Sameer Abed Mohammed2, Haneen Mushtaq Hameed3, Ahmed Flayyih Hasan3*, Hany M. El-Wahsh٤

1Department of Plant Biotechnology, College of Biotechnology, Al-Nahrain University, Baghdad, Iraq; 2Collage of pharmacy, University of Anbar, Anbar, Iraq; 3Biotechnology Research Center, Al-Nahrain University, Baghdad, Iraq; 4Marine Biology Department, King Abdulaziz University, Faculty of Marine Sciences, King Abdulaziz University, Saudi Arabia.

Abstract | The current study examined how Moringa oleifera protects male mice’s liver, kidney, and blood against the effects of cyclophosphamide (CP). Forty male Swiss albino mice were divided evenly into four groups (Gp1, control group; Gp2, Moringa oleifera group; Gp3, CP group; Gp4, CP+Moringa oleifera). The CP group had lower serum ALT, AST, and ALP levels than the control and Moringa oleifera groups. In contrast, the CP group’s blood albumin levels significantly increased in comparison to the control and Moringa oleifera groups. The CP group, on the other hand, experienced a significant increase in ALT, AST, and ALP levels and a drop in albumin level as a result of Moringa oleifera treatment. The CP group had lower levels of serum urea and creatinine than the Moringa oleifera and control groups. However, as compared to the control group, the group that received Moringa oleifera treatment had significantly higher blood urea and creatinine levels. Blood potassium and sodium ion levels were lower in the CP group than in the Moringa oleifera and control groups. However, the Moringa oleifera-treated CP group exhibited noticeably higher blood levels of potassium and sodium ions than the CP group. The CP group’s RBC and WBC levels and HB% were significantly lower than those of the control and Moringa oleifera groups; however, these changes are regulated and improved by Moringa oleifera treatment. These results exhibited that moringa has a potential to modify the liver and kidney biomarkers in CP-treated mice.

Keywords | Cyclophosphamide, Moringa oleifera, mice, CBC, liver Functions, kidney Functions


Received | March 05, 2025; Accepted | April 26, 2025; Published | May 15, 2025

*Correspondence | Ahmed Flayyih Hasan, Biotechnology Research Center, Al-Nahrain University, Baghdad, Iraq; Email: [email protected]

Citation | Razooki ZH, Mohammed SA, Hameed HM, Hasan AF, El-Wahsh HM (2025). Prophylactic action of Moringa oleifera against cyclophosphamide-induced harmful effects in male mice. J. Anim. Health Prod. 13(2): 335-339.

DOI | https://dx.doi.org/10.17582/journal.jahp/2025/13.2.335.339

ISSN (Online) | 2308-2801

Copyright: 2025 by the authors. Licensee ResearchersLinks Ltd, England, UK.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).



Introduction

Moringa oleifera is a rapidly growing tree that was first employed in traditional medicine in sub-Himalayan regions of Bangladesh, Pakistan, India, and Afghanistan. Among the ailments that the herbs are used to cure include nerve diseases (including hysteria, headaches, epilepsy, and muscular spasmodic (Fahey, 2005). According to earlier reports, Moringa oleifera leaves have nootropic properties that can improve memory (Mohan et al., 2005) most likely via changing the electrical activity and monoamine levels in the brain (Ganguly and Guha et al., 2008). Furthermore, it has been shown that the methanol extract from the leaves provides protection against seizures caused by pentylenetetrazole and convulsions induced by the maximum electroshock seizure test (Amrutia et al., 2011). Moringa leaves are abundant in vitamins (especially C and E), proteins, calcium, iron, potassium, β-carotene, and bioactive and antioxidant substances such tannins, saponins, glucosinolates and isothiocyanates, flavonoids, and phenolic acids. Thus, the many pharmacological qualities ascribed to Moringa oleifera leaves appear to have originated from Moringa leaves that were illuminated in many animal species (Chachar et al., 2024). Flavonoids and polyphenols are referred to be natural antioxidants in this context. The cycle of lipid peroxidation can be inhibited or broken by polyphenols and flavonoids because they may interact directly with lipid peroxyl radicals and superoxide anions (Tuorkey, 2016). cyclophosphamide (CP) is a well-researched teratogen that mostly causes skeletal and central nervous system abnormalities in humans, rats, mice, rabbits, and primates. Moreover, CP is among the antienoplastic substances that have been examined the most. According to recent research employing in vitro mouse embryo culture, CP has to be bioactivated in order to be teratogenic (Mirkes, 1985).

DNA cross-linking appears to be a key factor in the antineoplastic characteristics of CP, despite the fact that the nature of the DNA lesions that cause its teratogenic, mutagenic, and antineoplastic actions are not well known (Emadi et al., 2009). Cyclophosphamide that was injected quickly spread to 64% of body weight, and in individuals who had never taken the medication before, its half-life in plasma was 6.5 hours. At all dosage levels, no more than 20% of the injected cyclophosphamide was eliminated intact in the urine (De Jonge et al., 2005; Bagley et al., 1973). The aim of our study is to investigate the protective effect of Moringa oleifera against the toxic effect caused by cyclophosphamide in male mice.

Materials and Methods

Animals

Each of the 40 male Swiss albino mice weight between 20 and 25 grams were assigned at random to rooms with relative humidity and a 12-hour light/dark cycle, and an ambient temperature of 22 to 25 degrees Celsius. The animals were fed a commercial meal and unrestricted water for two weeks.

Experimental design and animal groups

Four groups of ten mice each were formed with equal numbers of animals: G1 – Control, G2 – Moringa oleifera, G3 – Cyclophosphamide (CP), and G4 – Cyclophosphamide (CP) + Moringa oleifera. A dry extract of Moringa oleifera, diluted in distilled water, was administered orally at a dosage of 250 mg/kg body weight daily for 14 days (Bakre et al., 2013). Cyclophosphamide (100 mg/kg body weight) was administered intraperitoneally as a single dose (Pavin et al., 2018). In the G4 group, CP was administered one hour after the final dose of the Moringa oleifera extract on the 14th day.

Sample collection

At the end of the experiment, the mice having fasted overnight were anesthetized, and two ocular blood samples were collected from each animal. To prevent clot formation, the first portion was drawn into a heparinized tube and mixed thoroughly before analysis for complete blood counts (CBCs). The second portion was centrifuged at 3000 rpm for 10 minutes at room temperature. The resulting serum was separated and stored at –20°C in sterile stoppered vials until analysis. The serum samples were used to assess kidney function and electrolyte levels.

Complete blood counts (CBC)

After being transferred to CBC tubes containing EDTA as an anticoagulant and kept in a cool box with ice packs, the blood samples were delivered directly to the lab for processing according to Hasan et al. (2022).

Biochemical assays

Serum creatinine and urea levels in mice were determined according to the method of Patton and Crouch (1977). Blood electrolyte levels, including potassium and sodium, were measured using pre-calibrated setups (Sensa Core Electrolyte Analyzer, India), following the procedures described by Hasan et al. (2024), Ezz et al. (2023), and Hameed et al. (2023). The activities of serum aspartate transaminase (AST) and alanine transaminase (ALT) were assessed using the method of Reitman and Frankel (1957), as reported by Hasan et al. (2024) and Al-Khuzaay et al. (2024). Serum albumin levels were determined according to the procedure described by Hasan et al. (2021).

Statistical analysis

The analysis was carried out using the Statistical Package for the Social Sciences (SPSS software version 16). The Least Significant Difference (LSD) tests and one-way ANOVA (Analysis of Variance) were used to statistically assess the data. The mean± standard error of mean (SEM) was used to present the data. The threshold for statistical significance was set at P<0.05. Group differences were assessed for significance using LSD comparisons.

Results

Effect of Moringa oleifera, and cyclophosphamide (CP) on liver function parameters in male mice

The data presented in Table 1 indicate that rats treated with cyclophosphamide exhibited a significant decrease (P < 0.05) in serum ALT, AST, and ALP levels, while liver albumin levels were significantly increased compared to the control group. However, co-administration of Moringa oleifera with cyclophosphamide helped maintain these parameters closer to normal values.

 

Table 1: Variations in liver function parameters among the study groups.

Groups

ALT (U/L)

AST (U/L)

Alb (g/dL)

ALP (U/L)

G1

43.4b ± 3.16

138.4b ± 3.13

5. 66b ± 0.08

130.1b ± 3.25

G2

39.7b ± 3.75

135.2b ± 4.50

5.50b ± 0.16

125.4b ± 5.22

G3

55.3a ± 2.77

177.3a ± 4.22

3.33a ± 0.22

150.1a ± 8.63

G4

47.4b±2.30

160.1ab ± 3.55

4.11b ± 0.30

136.7ab±6.33

 

Data are expressed as mean ± S.E.M of 8 observations. G1: Control; G2: Moringa oleifera; G3: Cyclophosphamide (CP); G4: Cyclophosphamide + Moringa oleifera; ALT: Alanine transaminase; AST: Aspartate transaminase; Alb: Albumin; ALP: Alkaline phosphatase. anotable distinction from the control group. bNotable distinction from the CP group.

 

Effect of Moringa oleifera, and cyclophosphamide (CP) on Kidney Functions and electrolytes in male mice

Data present in Table 2 showed that rats treated with cyclophosphamide caused significant decrease (P < 0.05) in serum urea, creatinine and Na+ while K+ in kidney was significantly increased as compared with control. The presence of Moringa oleifera with cyclophosphamide maintained the levels of the measured parameters closer to the normal values.

 

Table 2: Variations in the electrolyte and renal function parameters among the study groups.

Groups

Urea (mg/dL)

Creatinine (mg/dL)

Na+ (mmol/L)

K+ (mmol/L)

G1

26.1b± 2.02

0.42b ± 0.11

133.3b± 5.11

6.30b±0.22

G2

24.1b ± 2.32

0.41 b± 0.01

131.9b± 5.23

4.21b±0.13

G3

33.3a± 1.03

0.55a ± 0.04

139.0a ± 6.11

3.11a±0.11

G4

29.7ab± 1.21

0.47b ± 0.02

136.9b± 5.11

4.60ab±0.02

 

Data are expressed as mean ± S.E.M of 8 observations. G1: Control; G2: Moringa oleifera; G3: Cyclophosphamide (CP); G4: Cyclophosphamide + Moringa oleifera. anotable distinction from the control group. bNotable distinction from the CP group.

 

Effect of Moringa oleifera, and cyclophosphamide (CP) on hematological parameters in male mice

Data present in Table 3 showed that rats treated with cyclophosphamide exhibited significant decline (P < 0.05) in serum RBCs ,WBCs while Hb in kidney was non affected as compared with control. The presence of Moringa oleifera with cyclophosphamide maintained the levels of the measured parameters closer to the normal values.

Discussion

Moringa oleifera has not been shown to aid in weight loss or significantly alter illness risk factors in overweight individuals. However, in this study, the administered dosage of Moringa oleifera did not produce any adverse effects in experimental animals, as also reported by Fakurazi et al. (2008), Onah et al. (2016), Priyadarshani and Verma (2014), and Alia et al. (2019).

 

Table 3: Variations in RBCs, Hb%, and WBCs levels among the various research groups.

Groups

RBCs (106/ml)

Hb (g/dL)

WBCs (103/ml)

G1

7.59b ± 0.12

14.2b ± 1.11

7. 61b± 0.11

G2

6.62b ± 0.02

14.2b ± 0.03

7.77b ± 0.20

G3

9.80a± 0.11

11.1a ± 0.12

10.11a ± 0.19

G4

6.16ab±0.23

12.1ab ± 1.02

7.23b ± 0.09

 

Data are expressed as mean ± S.E.M of 8 observations. G1: Control; G2: Moringa oleifera; G3: Cyclophosphamide (CP); G4: Cyclophosphamide + Moringa oleifera; RBCs: Red blood cells; Hb: Hemoglobin; WBCs: White blood cells. anotable distinction from the control group. bhardly any difference from the CP group.

 

According to the current investigation, cyclophosphamide (CP)-induced hepatic dysfunction was evidenced by a significant decrease in serum albumin levels and increased activities of serum ALT, AST, and ALP. These findings confirm that CP causes liver impairment, consistent with previous studies by Juma (1984) and Shokrzadeh et al. (2015). However, co-treatment with Moringa oleifera appeared to improve liver function, as reflected by more normalized levels of these parameters. Our results align with those of Nurhayati et al. (2024) and Aja et al. (2015), who also reported hepatoprotective effects of Moringa oleifera.

In terms of renal function, CP administration resulted in elevated levels of urea, creatinine, and potassium ions (K), alongside decreased levels of sodium (Na) and calcium ions (Ca²). These disturbances suggest renal dysfunction, likely due to CP-induced damage to renal tissues. This outcome supports the findings of Defronzo et al. (1974), Dobrek et al. (2017), and Bhat et al. (2018), who similarly observed elevated creatinine, urea, and potassium levels following CP exposure. Notably, treatment with Moringa oleifera improved renal function and helped restore electrolyte balance, consistent with the observations of Wen et al. (2022) and Saleh and Sarhat (2019).

Additionally, CP treatment significantly reduced hemoglobin percentage (Hb%) and red blood cell (RBC) counts compared to the control group. However, administration of Moringa oleifera effectively moderated these hematological changes. While white blood cell (WBC) counts were significantly elevated in the CP group compared to both the control and Moringa oleifera groups, WBC levels were lower in the Moringa oleifera-treated group compared to the CP-only group. These observations are supported by findings from Idoko et al. (2024) and Ufelle et al. (2018).

Conclusions

The experimental animals did not exhibit any adverse effects from the administered dosage of Moringa oleifera. Overall, Moringa oleifera demonstrated a protective effect against cyclophosphamide-induced hematological and biochemical alterations in mice.

Acknowledgments

No funding agency awarded a grant for this work.

Novelty Statement

The study investigated the efficacy of Moringa oleifera at a dose of 250 mg/kg body weight against toxicity caused by Cyclophosphamide in male mice.

Author’s Contribution

Ahmed Flayyih Hasan ,Haneen Mushtaq Hameed: They prepared the plan, designed the study, prepared the materials, photographed and performed the statistical analysis.Zainab Haytham Razooki,Sameer Abed Mohammed ,Hany M. El-Wahsh: They wrote, organized the images and references, and also helped answer reviewers’ comments.

Ethical approval

The study protocol was approved by our Institutional Animal Care and Use Committee. Animals were housed at the Biotechnology Research Center, Al-Nahrain University, under randomly assigned conditions that included a 12-hour light/dark cycle, relative humidity, an ambient temperature of 22–25 °C, and ad libitum access to commercial food and water for two weeks prior to experimentation.

Data availability

Whenever necessary, the appropriate author can provide the data supporting the findings of our study.

Funding

No financial support for our research.

Conflict of interest

The authors have declared no conflict of interest.

References

Aja PM, Igwenyi IO, Okechukwu PU, Orji OU, Alum EU (2015). Evaluation of anti-diabetic effect and liver function indices of ethanol extracts of Moringa oleifera and Cajanus cajan leaves in alloxan induced diabetic albino rats. Glob. Vet., 14(3): 439-447.

Alia F, Syamsunarno MRA, Sumirat VA, Ghozali M, Atik N (2019). The haematological profiles of high fat diet mice model with Moringa oleifera leaves ethanol extract treatment. Biomed. Pharmacol. J., 12(4): 2143-2149. https://doi.org/10.13005/bpj/1849

Al-Khuzaay HM, Al-Juraisy YH, Hasan AF, Tousson E (2024). Antitumor activity of β-glucan isolated аrom date fruits щn cancer cells in vivo. Opera Med. Physiol., 11(3): 41-48.

Amrutia JN, Lala M, Srinivasa U, Shabaraya AR, Semuel MR (2011). Anticonvulsant activity of Moringa oleifera leaf. Int. Res. J. Pharm., 2(7): 160-162.

Bagley Jr CM, Bostick FW, DeVita Jr VT (1973). Clinical pharmacology of cyclophosphamide. Cancer Res., 33(2): 226-233.

Bakre AG, Aderibigbe AO, Ademowo OG (2013). Studies on neuropharmacological profile of ethanol extract of Moringa oleifera leaves in mice. J. Ethnopharmacol., 149(3): 783-789. https://doi.org/10.1016/j.jep.2013.08.006

Bhat N, Kalthur SG, Padmashali S, Monappa V (2018). Toxic effects of different doses of cyclophosphamide on liver and kidney tissue in Swiss albino mice: A histopathological study. Ethiop. J. Health Sci., 28(6). https://doi.org/10.4314/ejhs.v28i6.5

Chachar RA, Kamboh AA, Bakhetgul M (2024). Individual and combined effects of moringa and neem leaves on immune response and gut microflora in Japanese quails. Pak. J. Zool., (56): 1-9. https://doi.org/10.17582/journal.pjz/20220613130629

De Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH (2005). Clinical pharmacokinetics of cyclophosphamide. Clin. Pharmacokinetics, 44(11): 1135-1164. https://doi.org/10.2165/00003088-200544110-00003

Defronzo RA, Colvin OM, Braine H, Robertson GL, Davis PJ (1974). Cyclophosphamide and the kidney. Cancer, 33(2): 483-491. https://doi.org/10.1002/1097-0142(197402)33:2<483::AID-CNCR2820330224>3.0.CO;2-P

Dobrek L, Baranowska A, Skowron B, Thor P (2017). Biochemical and histological evaluation of kidney function in rats after a single administration of cyclophosphamide and ifosfamide. J. Nephrol. Kidney Dis., 1(1): 1002-1008. https://doi.org/10.36876/smjnkd.1002

Emadi A, Jones RJ, Brodsky RA (2009). Cyclophosphamide and cancer: Golden anniversary. Nat. Rev. Clin. Oncol., 6(11): 638-647. https://doi.org/10.1038/nrclinonc.2009.146

Ezz AM, Zaki S, Tabl GA (2023). Anti-diabetic effects of pomegranate peel extract and L-carnitine on streptozotocin induced diabetes in rats. Biomed. Pharmacol. J., 16(3): 1827-1835. https://doi.org/10.13005/bpj/2762

Fahey JW (2005). Moringa oleifera: A review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees Life J., 1(5): 1-15.

Fakurazi S, Hairuszah I, Nanthini U (2008). Moringa oleifera Lam prevents acetaminophen induced liver injury through restoration of glutathione level. Food Chem. Toxicol., 46(8): 2611-2615. https://doi.org/10.1016/j.fct.2008.04.018

Ganguly R, Guha D (2008). Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer’s disease & protection by Moringa oleifera. Indian J. Med. Res., 128(6): 744-751.

Hameed HM, Hasan AF, Razooki ZH, Tousson E, Fatoh SA (2023). Orlistat induce renal toxicity, DNA damage, and apoptosis in normal and obese female rats. Online J. Biol. Sci., 23(1): 25-32. https://doi.org/10.3844/ojbsci.2023.25.32

Hasan AF, Alankooshi AA, Modher MN, El-Naggar SA, El-Wahsh HM, El-Bagoury AE, Kabil DI (2024). Artemisia annua extract ameliorates hepato-renal dysfunctions in obese rats. Opera Med. Physiol., 11(2): 47-65.

Hasan AF, Hameed HM, Hadid MA, Tousson E (2024). Impact of chia (Salvia hispanica) seeds extract on ehrlich ascites model induced kidney toxicity in female mice. Asian J. Dairy Food Res., 10. https://doi.org/10.18805/ajdfr.DRF-397

Hasan AF, Hameed HM, Tousson E, Massoud A, Atta F, Youssef H (2022). Role of oral supplementation of damiana (Turnera diffusa) reduces the renal toxicity, apoptosis and DNA damage associated with amitriptyline administration in rats. Biomed. Pharmacol. J., 15(3): 1245-1253. https://doi.org/10.13005/bpj/2460

Hasan AF, Jasim NA, Abid AT, Tousson E (2024). Role of Salvia hispanica seeds extract on Ehrlich ascites model induced liver damage in female mice. J. Biosci. Appl. Res., 10(2): 161-169. https://doi.org/10.18805/ajdfr.DRF-397

Hasan AF, Mutar TF, Tousson EM, Felemban SG (2021). Therapeutic effects of Turnera diffusa extract against amitriptyline-induced toxic hepatic inflammation. Online J. Biol. Sci., 21(2): 395-408. https://doi.org/10.3844/ojbsci.2021.395.408

Idoko IS, Orakpoghenor O (2024). Hematological effects of lead exposure and Moringa intervention in rats. Sci. Rep. Life Sci., 5(3): 24-36.

Juma FD (1984). Effect of liver failure on the pharmacokinetics of cyclophosphamide. Eur. J. Clin. Pharmacol., 26: 591-593. https://doi.org/10.1007/BF00543491

Mirkes PE (1985). Cyclophosphamide teratogenesis: A review. Teratogen. Carcinogen. Mutagen., 5(2): 75-88. https://doi.org/10.1002/tcm.1770050202

Mohan, S.V., Rao, N.C., Prasad, K.K., Madhavi, B.T.V., and Sharma, P.N. (2005). Treatment of complex chemical wastewater in a sequencing batch reactor (SBR) with an aerobic suspended growth configuration. Process biochemistry, 40(5), 1501-1508.

Nurhayati T, Ridho MF, Santoso PTR, Setiawan S, Goenawan H, Tarawan VM (2024). Effects of Moringa oleifera leaf extract on liver histopathology: A systematic review. J. Nutr. Metab., 2024(1): 6815993. https://doi.org/10.1155/2024/6815993

Onah CE, Meludu SC, Dioka CE, Onuegbu AJ, Onah CF, Ajaghaku DL, Ejeatuluchukwu O (2016). Amelioratory effect of methanolic leaf extract of Moringa oleifera on some liver and kidney function and oxidative stress markers in lead-intoxicated rats. Eur. J. Med. Plants, 12(4): 1-12. https://doi.org/10.9734/EJMP/2016/23763

Patton, C.J., and Crouch, S.R. (1977). Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Analytical chemistry, 49(3), 464-469.

Pavin NF, Izaguirry AP, Soares MB, Spiazzi CC, Mendez ASL, Leivas FG, Cibin FWS (2018). Tribulus terrestris protects against male reproductive damage induced by cyclophosphamide in mice. Oxid. Med. Cell. Long., 2018(1): 5758191. https://doi.org/10.1155/2018/5758191

Priyadarshani N, Varma MC (2014). Effect of Moringa oleifera leaf powder on sperm count, histology of testis and epididymis of hyperglycaemic mice Mus musculus. Am. Int. J. Res. Form. Appl. Nat. Sci., 7: 7-13.

Reitman, S., and Frankel, S. (1957). A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American journal of clinical pathology, 28(1), 56-63.

Saleh SS, Sarhat ER (2019). Effects of ethanolic Moringa oleifera extract on melatonin, liver and kidney function tests in alloxan-induced diabetic rats. Indian J. Forensic Med. Toxicol., 13(4): 1015-1019. https://doi.org/10.5958/0973-9130.2019.00431.6

Shokrzadeh M, Chabra A, Ahmadi A, Naghshvar F, Habibi E, Salehi F, Assadpour S (2015). Hepatoprotective effects of Zataria multiflora ethanolic extract on liver toxicity induced by cyclophosphamide in mice. Drug Res., 65(4): 169-175. https://doi.org/10.1055/s-0034-1370932

Tuorkey MJ (2016). Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice. Int. Med. Appl. Sci., 8(3): 109-117. https://doi.org/10.1556/1646.8.2016.3.7

Ufelle SA, Onyekwelu KC, Achukwu PU, Ezeh CO, Ghasi S (2018). Haematological effects of leaf extract of Moringa oleifera Lam in normal and myelo-suppressed wistar rats. Afr. J. Biomed. Res., 21(1): 87-90.

Wen Y, Liu Y, Huang Q, Liu R, Liu J, Zhang F, Jiang Y (2022). Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway. Phytomedicine, 95: 153856. https://doi.org/10.1016/j.phymed.2021.153856